Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Other Non-Current Liabilities (2022 - 2024)

Whitehawk Therapeutics (WHWK) has disclosed Other Non-Current Liabilities for 2 consecutive years, with $202000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A to $202000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $202000.0, a N/A change, with the full-year FY2024 number at $202000.0, changed N/A from a year prior.
  • Other Non-Current Liabilities was $202000.0 for Q4 2024 at Whitehawk Therapeutics, down from $393000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $393000.0 in Q3 2024 to a low of $109000.0 in Q2 2022.